Back |
home / stock / indp / indp message board
Subject | By | Source | When |
---|---|---|---|
$12'S AGAIN $ANY SHELF OR OTHER OFFERINGS? | TheFinalCD | investorshub | 09/15/2021 5:57:47 PM |
any news of offering? is that why the drop? | madras50 | investorshub | 09/15/2021 5:56:12 PM |
$13'S BACK AGAIN= WOOOOOOOOOW | TheFinalCD | investorshub | 09/15/2021 5:55:59 PM |
15's from 28's | TheFinalCD | investorshub | 09/15/2021 5:45:44 PM |
Holy shit......lol | Zardiw | investorshub | 09/15/2021 4:26:12 PM |
My best day in September so far ... | cityimport | investorshub | 09/15/2021 4:04:42 PM |
Nice move. A lot of folks still averaging | otterman | investorshub | 09/15/2021 4:02:03 PM |
Another Round: 10,000 shares at 19 and out | cityimport | investorshub | 09/15/2021 3:57:15 PM |
$25= $$$$$$$$$$$$$$$$ | TheFinalCD | investorshub | 09/15/2021 3:53:20 PM |
$28 Weeeeeeeeeeeeeeeeeeee hahahahahahaha | MonstaGains | investorshub | 09/15/2021 3:51:08 PM |
$23's going gahhhhhhh damnnnnnnn weeeeee | MonstaGains | investorshub | 09/15/2021 3:44:17 PM |
We in dis b! | MonstaGains | investorshub | 09/15/2021 3:43:30 PM |
GAaaaahhhhhhhhhhhhhHHHHHHHH GAHHHHHHHHHH GAHHHHHHH MOW EM WALLS DOWN WIT | MonstaGains | investorshub | 09/15/2021 3:43:06 PM |
POP POP POP POP cuhhhhhhhh | MonstaGains | investorshub | 09/15/2021 3:40:20 PM |
Here we go folks! Another $NURO in the | MonstaGains | investorshub | 09/15/2021 3:39:44 PM |
Stop holding us back let us MOOOOOON! | MonstaGains | investorshub | 09/15/2021 3:39:05 PM |
Ooooooooo weeeeeee this is so coiled up once | MonstaGains | investorshub | 09/15/2021 3:36:29 PM |
Yes!!!!! LETS GO! Break that HOD and this | MonstaGains | investorshub | 09/15/2021 3:35:47 PM |
News, Short Squeeze, Breakout and More Instantly...
Indaptus Therapeutics Inc. Company Name:
INDP Stock Symbol:
NASDAQ Market:
Indaptus Therapeutics Inc. Website:
- Chief Scientific Officer Dr. Newman to present initial clinical data that further validates Company’s “Pulse-Prime” hypothesis - Dr. Newman also named Chair of the Summit NEW YORK, June 11, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc, (Nasdaq: INDP), a...
NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc, (Nasdaq: INDP), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, today announced that its Chief Medical Officer, Roger Waltzman, M.D., will present an update on ...
Latest data from first and second cohorts support Company’s 'pulse-prime' approach, demonstrating rapid clearance, broad immune activation, and encouraging safety profile Poster Presented at American Society of Clinical Oncology Annual Meeting NEW YORK, June 03, 2024 (GLOBE...